Literature DB >> 11887351

[Polymicrobial infective endocarditis in Italy].

Stefania Cicalini1, Rosa Francavilla, Katia Massaroni, Francesco Giuseppe De Rosa.   

Abstract

In our series, including 1053 cases of infective endocarditis (IE) collected from 86 Infectious Diseases Centres in Italy between 1984 and 1999, we identified 34 cases (3.2%) with a polymicrobial etiology. Intravenous drug abuse was the most important risk factor for the development of polymicrobial IE. Twenty three patients had a left sided-IE and 6 patients had a right-sided IE. The most commonly encountered microorganisms were Staphylococci and Streptococci and the most frequently observed associations of microorganisms were those between Staphylococci and Gram-negative bacteria and between Staphylococci and fungi. Twelve patients (35.3%) underwent surgery, and 5 patients (16.7%) died. Polymicrobial endocarditis did not differ clinically from IE caused by a single microorganism, and the prognosis seems to be related to the site of infection and to some specific pathogens.

Entities:  

Mesh:

Year:  2002        PMID: 11887351

Source DB:  PubMed          Journal:  Recenti Prog Med        ISSN: 0034-1193


  3 in total

1.  Native valve dual pathogen endocarditis caused by Burkholderia cepacia and Aspergillus flavus - a case report.

Authors:  Nargis Sabir; Aamer Ikram; Adeel Gardezi; Gohar Zaman; Luqman Satti; Abeera Ahmed; Tahir Khadim
Journal:  JMM Case Rep       Date:  2018-03-08

2.  Staphylococcus aureus and Escherichia hermanii in diabetes patient.

Authors:  Gabriel Adrian Popescu; Ioana Daha; Cristina Popescu; Elena Mitache
Journal:  Emerg Infect Dis       Date:  2004-07       Impact factor: 6.883

3.  Polymicrobial Infective Endocarditis: Clinical Features and Prognosis.

Authors:  Pablo Elpidio García-Granja; Javier López; Isidre Vilacosta; Carlos Ortiz-Bautista; Teresa Sevilla; Carmen Olmos; Cristina Sarriá; Carlos Ferrera; Itziar Gómez; José Alberto San Román
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.